TBnet webinar "Decoding resistance: Interpreting genotypic drug susceptibility results for M. tuberculosis" on July 10, 2025
- anneoleischeck
- Jun 13
- 1 min read
Dear Colleagues,
We invite you to join us on 10 July 2025 at 17:00 CET for the newest TBnet webinar with the topic “Decoding resistance: Interpreting genotypic drug susceptibility results for M. tuberculosis”. We look forward to your participation!
Please register for this webinar in advance using the link below:
After registering, you will receive a confirmation email containing information about joining the webinar
Contact information: admin@tbnet.eu
Speakers:
Dr Claudio Köser is a visiting scientist at the Department of Genetics, University of Cambridge. He works as a consultant for WHO, the TB Alliance, and the diagnostic industry. His main interest lies in bringing modern microbiological principles to defining susceptibility and resistance to anti-TB agents on the phenotypic and genotypic level.
Dr Andrea Cabibbe is research associate at the TB Supranational Reference Laboratory in San Raffaele Hospital (Milan, Italy), with more than 10 years of experience in TB-related translational research, drug resistant surveillance and diagnosis, and technical assistance to national TB programmes and laboratories. He is member of the Global Laboratory Initiative core group of the Stop TB Partnership and Associate Editor for The International Journal of Tuberculosis and Lung Disease.
Chair:
Dr Francesca Saluzzo is a physician specialized in Microbiology and Virology with an MSc in International Health. Currently she is working at Vita Salute San Raffaele University in Milan, Italy. Her research focuses on the validation and implementation of new diagnostic tools and frameworks for drug resistant tuberculosis and respiratory infectious diseases opting for a participatory and people centred approach. Within TBnet she is responsible for Microbiology.
Comments